BOUNDLESS BIO, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.24 USD | -1.60% |
|
-0.33% | 0.00% |
| 22/04 | Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target | MT |
| 22/04 | Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target | MT |
Chart calendar Boundless Bio, Inc.
e.ILOvMQM9Mt2oT669528OQX0wy2So9B4YxXql-_1RrY0.b-fIAWULV6nsBsn_ohV4eCp4_wntmXh1_E3EtqdnlfVD5tplU016qZ8-9w~b1c059f355af597cb01fc6c658e291f9
Upcoming events on Boundless Bio, Inc.
Past events on Boundless Bio, Inc.
| 13/05/2024 10:30 pm | Citizens JMP Life Sciences Conference |
| 13/05/2024 04:30 pm | Q1 2024 Earnings Release |
| 10/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster Number: 14 |
| 09/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster Number: 9 |
| 08/04/2024 02:00 am | American Association for Cancer Research Meeting - Poster Number: 23 |
Annual results
| Fiscal Period | December | 2023 | 2024 |
|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -72,7 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -75,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -71,2 |
|
Net income Million USD | Released Forecast Spread | -49,4 | -69,2 |
|
EPS USD | Released Forecast Spread | -2,08 | -7,64 |
| Announcement Date | 06/03/24 | - |
Quarterly results
| Fiscal Period | December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -16,9 -15,4 -9.51% | -18,3 | -19,5 | -20,5 | -22,8 | -23,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,4 -16,3 5.05% | -17,6 | -18,4 | -19,7 | -21,1 | -22,8 |
|
Net income Million USD | Released Forecast Spread | -15,4 -15,6 1.3% | -17,5 | -18,4 | -19,6 | -21,1 | -22,8 |
|
EPS USD | Released Forecast Spread | -12,3 -0,74 -1569.39% | -0,80 | -0,82 | -0,86 | -0,94 | -1,02 |
| Announcement Date | 13/05/24 | - | - | - | - | - |
More events
Past sector events for Boundless Bio, Inc.
| 05/06/2024 01:21 pm | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 05:16 pm | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 10:30 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 16/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 05:35 pm | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:35 am | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 01:30 am | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BOLD Stock
- Calendar Boundless Bio, Inc.
